111 related articles for article (PubMed ID: 2831047)
21. Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin.
Niu WW; Neu HC
Antimicrob Agents Chemother; 1991 May; 35(5):998-1000. PubMed ID: 1649577
[TBL] [Abstract][Full Text] [Related]
22. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.
Del Bene VE; John JF; Twitty JA; Lewis JW
J Infect Dis; 1986 Aug; 154(2):349-52. PubMed ID: 2941491
[No Abstract] [Full Text] [Related]
23. [Bactericidal effect of daptomycin (LY 146032) compared with vancomycine and teicoplanin against gram-positive bacteria].
Caillon J; Juvin ME; Pirault JL; Drugeon HB
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):540-8. PubMed ID: 2552378
[TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of in vitro activity of teicoplanin and vancomycin against coagulase negative methicillin resistant staphylococci isolated from high-risk patients.
Battista C; Panza N; Chiurazzi B; Romano A; Pacilio G; Amato G; Gargiulo F; Bolletti Censi M; Bocchetti M
Biomed Pharmacother; 1991; 45(1):43. PubMed ID: 1828377
[No Abstract] [Full Text] [Related]
25. Susceptibility of staphylococci to teicoplanin and vancomycin.
Murphy OM; Stewart D; Gray J; Bint AJ
J Antimicrob Chemother; 1996 Aug; 38(2):316-7. PubMed ID: 8877549
[No Abstract] [Full Text] [Related]
26. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin.
Cooper MA; Jin YF; Ashby JP; Andrews JM; Wise R
J Antimicrob Chemother; 1990 Aug; 26(2):203-7. PubMed ID: 2145256
[TBL] [Abstract][Full Text] [Related]
27. Comparative in vitro activity of daptomycin (LY146032) and vancomycin against gram-positive cocci determined using a pharmacokinetic model.
Blenkharn JI; Darrell JH
Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):734-7. PubMed ID: 2550236
[TBL] [Abstract][Full Text] [Related]
28. Time-kill studies with oxacillin, vancomycin, and teicoplanin versus Staphylococcus aureus.
Greenberg RN; Benes CA
J Infect Dis; 1990 May; 161(5):1036-7. PubMed ID: 2139086
[No Abstract] [Full Text] [Related]
29. [Recent trend and development of novel antimicrobial agents for MRSA infections].
Nishino T
Nihon Rinsho; 1992 May; 50(5):1066-74. PubMed ID: 1324332
[TBL] [Abstract][Full Text] [Related]
30. The influence of human monocytes on the antibacterial activity of vancomycin and teicoplanin against Staphylococcus aureus.
van der Broek PJ; Buys LF
J Antimicrob Chemother; 1990 May; 25(5):787-95. PubMed ID: 2142684
[TBL] [Abstract][Full Text] [Related]
31. In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin.
Watanakunakorn C
J Antimicrob Chemother; 1990 Jan; 25(1):69-72. PubMed ID: 2138602
[TBL] [Abstract][Full Text] [Related]
32. The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci.
Felmingham D; Solomonides K; O'Hare MD; Wilson AP; Grüneberg RN
J Antimicrob Chemother; 1987 Oct; 20(4):609-10. PubMed ID: 2960645
[No Abstract] [Full Text] [Related]
33. Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative Staphylococcus.
Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):212-4. PubMed ID: 22608137
[TBL] [Abstract][Full Text] [Related]
34. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
Watanakunakorn C
J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
Kucukates E; Nalan Karayel E; Gultekin N; Okuyan E; Kansiz E; Gurler N
Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323
[No Abstract] [Full Text] [Related]
36. A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin.
Greenwood D; Bidgood K; Turner M
J Antimicrob Chemother; 1987 Aug; 20(2):155-64. PubMed ID: 2959642
[TBL] [Abstract][Full Text] [Related]
37. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
Kayaokay Y; Hasçelik G; Gür D; Akalin E
Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
[TBL] [Abstract][Full Text] [Related]
38. Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance.
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López-Fabal F; Gómez M;
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):373-9. PubMed ID: 21683269
[TBL] [Abstract][Full Text] [Related]
39. LY146032: activity and resistance development in vitro.
Mouton RP; Mulders SL
J Antimicrob Chemother; 1987 Oct; 20(4):513-7. PubMed ID: 2824427
[TBL] [Abstract][Full Text] [Related]
40. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.
Barr JG; Smyth ET; Hogg GM
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):804-9. PubMed ID: 2150814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
